HLA-B18 as risk factor of liver fibrosis progression in HIV/HCV treatment-experienced patients.

Pharmacogenomics J

Infectious Diseases Unit, Hospital Universitario Reina Sofía de Córdoba, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Universidad de Córdoba (UCO), Cordoba, Spain.

Published: December 2017

Download full-text PDF

Source
http://dx.doi.org/10.1038/tpj.2016.80DOI Listing

Publication Analysis

Top Keywords

hla-b18 risk
4
risk factor
4
factor liver
4
liver fibrosis
4
fibrosis progression
4
progression hiv/hcv
4
hiv/hcv treatment-experienced
4
treatment-experienced patients
4
hla-b18
1
factor
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!